Zacks.com on MSN1h
Bristol Myers Squibb (BMY) Advances While Market Declines: Some Information for Investors
Bristol Myers Squibb (BMY) closed at $54.20 in the latest trading session, marking a +0.82% move from the prior day. This change outpaced the S&P 500's 0.17% loss on the day. Meanwhile, the Dow lost 0 ...
stocknews3h
3 Pharmaceutical Stocks That Could Lead the Next Drug Revolution
The pharmaceutical industry is promising due to AI and biotech innovations enhancing productivity, steady profits amidst ...
bovnews4h
Why Did Bristol-Myers Squibb Co (BMY) Stock See 34.20% Surge in the Last 90 Days?
On Wednesday, Bristol-Myers Squibb Co (BMY) stock saw a modest uptick, ending the day at $53.76 which represents a slight increase of $0.86 or 1.63% from the prior close of $52.9. The stock opened at ...
Buying Bristol-Myers Now For A Big Dividend Tomorrow
If we earn tomorrow’s dividend and then get assigned at expiration on October 25, we will earn $1.65 per share on $52.95 per ...
Bristol-Myers wins FDA nod for Opdivo lung cancer indication
Bristol-Myers Squibb (BMY) wins FDA nod to expand the U.S. label for its blockbuster immunotherapy Opdivo in lung cancer.
2 Passive-Income Stocks to Load Up On in October
Dividend investing can create substantial passive income over time. A conservative example illustrates this potential: ...